Publications by authors named "Koen Norga"

Claim this Profile
A
Adjuvant Wilms' tumour 1-specific dendritic cell immunotherapy complementing conventional therapy for paediatric patients with high-grade glioma and diffuse intrinsic pontine glioma: protocol of a monocentric phase I/II clinical trial in Belgium.
Toon Van Genechten, Maxime De Laere, Jolien Van den Bossche, Barbara Stein, Kim De Rycke, Koen Norga

BMJ Open· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of ACCELERATE Paediatric Strategy Forums: a review of the value of multi-stakeholder meetings in oncology drug development.
Andrew D J Pearson, Teresa de Rojas, Dominik Karres, Gregory Reaman, Nicole Scobie, Koen Norga

J Natl Cancer Inst· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Paediatric Strategy Forum for medicinal product development of DNA damage response pathway inhibitors in children and adolescents with cancer: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration.
Andrew D J Pearson, Sara Federico, Susanne A Gatz, Michael Ortiz, Giovanni Lesa, Koen Norga

Eur J Cancer· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dilemmas in the Management of an Infant with Neuroblastoma Metastasized to the Muscles.
Jaques van Heerden, Machiel van den Akker, Joris Verlooy, Nadine Van Roy, Geneviève Laureys, Koen Norga

Case Rep Oncol· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploring residents and supervisors' workplace learning needs during postgraduate medical education.
Marieke Robbrecht, Myriam Van Winckel, Koen Norga, Mieke Embo

Int J Med Educ· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Paediatric Inflammatory Bowel Disease: A Multi-Stakeholder Perspective to Improve Development of Drugs for Children and Adolescents.
Nicholas M Croft, Lissy de Ridder, Anne M Griffiths, Jeffrey S Hyams, Frank M Ruemmele, Koen Norga

J Crohns Colitis· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pre-Clinical Evaluation of the Hypomethylating Agent Decitabine for the Treatment of T-Cell Lymphoblastic Lymphoma.
Lien Provez, Tom Putteman, Mattias Landfors, Juliette Roels, Lindy Reunes, Koen Norga

Cancers (Basel)· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
European regulatory strategy for supporting childhood cancer therapy developments.
Dominik Karres, Giovanni Lesa, Franca Ligas, Sylvie Benchetrit, Sara Galluzzo, Koen Norga

Eur J Cancer· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Paediatric Strategy Forum for medicinal product development in mitogen-activated protein kinase pathway inhibitors: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration.
Andrew Dj Pearson, Carl Allen, Jason Fangusaro, Caroline Hutter, Olaf Witt, Koen Norga

Eur J Cancer· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ACCELERATE Paediatric Strategy Forums: an advance for oncological drug development?
Andrew D J Pearson, Teresa de Rojas, Dominik Karres, Gregory Reaman, Nicole Scobie, Koen Norga

Lancet Oncol· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Paediatric Strategy Forum for medicinal product development of multi-targeted kinase inhibitors in bone sarcomas: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration.
Andrew Dj Pearson, Nathalie Gaspar, Katherine Janeway, Quentin Campbell-Hewson, Elizabeth R Lawlor, Koen Norga

Eur J Cancer· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Fusions in a Sarcomas Series: Pathology, Molecular and Clinical Aspects.
Vasiliki Siozopoulou, Elly Marcq, Koen De Winne, Koen Norga, Gertjan Schmitz

Pathol Oncol Res· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ACCELERATE - Five years accelerating cancer drug development for children and adolescents.
Andrew D J Pearson, Susan L Weiner, Peter C Adamson, Dominik Karres, Gregory Reaman, Koen Norga

Eur J Cancer· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of an integrated competency framework for postgraduate paediatric training: a Delphi study.
Marieke Robbrecht, Koen Norga, Myriam Van Winckel, Martin Valcke, Mieke Embo

Eur J Pediatr· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Paediatric Strategy Forum for medicinal product development of chimeric antigen receptor T-cells in children and adolescents with cancer: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration.
Andrew Dj Pearson, Claudia Rossig, Crystal Mackall, Nirali N Shah, Andre Baruchel, Koen Norga

Eur J Cancer· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Second Paediatric Strategy Forum for anaplastic lymphoma kinase (ALK) inhibition in paediatric malignancies: ACCELERATE in collaboration with the European Medicines Agency with the participation of the Food and Drug Administration.
Andrew D J Pearson, Elly Barry, Yael P Mossé, Franca Ligas, Nick Bird, Koen Norga

Eur J Cancer· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Together Against Leukemia-the Strength of a Small Community.
Bart Jonckers, Toke Michielsen, Nina Severijns, Heidi Elst, Fried'l Simoens, Koen Norga

J Patient Exp· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Challenges of Crizotinib Treatment in a Child With Anaplastic Large Cell Lymphoma.
Liesbeth Vanheeswijck, Joris Verlooy, Els Van de Vijver, An Bervoets, Katleen Balliauw, Koen Norga

J Pediatr Pharmacol Ther· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Accelerating the Global Development of Pediatric Cancer Drugs: A Call to Coordinate the Submissions of Pediatric Investigation Plans and Pediatric Study Plans to the European Medicines Agency and US Food and Drug Administration.
Gregory Reaman, Dominik Karres, Franca Ligas, Giovanni Lesa, Denise Casey, Koen Norga

J Clin Oncol· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Paediatric Strategy Forum for medicinal product development of epigenetic modifiers for children: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration.
Andrew Dj Pearson, Kimberly Stegmaier, Franck Bourdeaut, Gregory Reaman, Delphine Heenen, Koen Norga

Eur J Cancer· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Can a Multistakeholder Prioritization Structure Support Regulatory Decision Making? A Review of Pediatric Oncology Strategy Forums Reflecting on Challenges and Opportunities of this Concept.
Dominik Karres, Giovanni Lesa, Franca Ligas, Pia Annunen, Maaike van Dartel, Koen Norga

Clin Pharmacol Ther· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Paediatric Strategy Forum for medicinal product development for acute myeloid leukaemia in children and adolescents: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration.
Andrew D J Pearson, C Michel Zwaan, E Anders Kolb, Dominik Karres, Julie Guillot, Koen Norga

Eur J Cancer· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Accelerating drug development for neuroblastoma - New Drug Development Strategy: an Innovative Therapies for Children with Cancer, European Network for Cancer Research in Children and Adolescents and International Society of Paediatric Oncology Europe Neuroblastoma project.
Lucas Moreno, Hubert Caron, Birgit Geoerger, Angelika Eggert, Gudrun Schleiermacher, Koen Norga

Expert Opin Drug Discov· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chemotherapy drug shortages in paediatric oncology: A 14-year single-centre experience in Belgium.
Tiene Bauters, Barbara Om Claus, Koen Norga, Isabelle Huys, Steven Simoens

J Oncol Pharm Pract· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Implementation of mechanism of action biology-driven early drug development for children with cancer.
Andrew D J Pearson, Ralf Herold, Raphaël Rousseau, Chris Copland, Brigid Bradley-Garelik, Koen Norga

Eur J Cancer· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis